Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

Shares of Snowflake Inc. (NYSE:SNOW) rose sharply in pre-market trading after the company reported second-quarter financial results and beat its adjusted EPS and revenue estimates.

Snowflake reported second-quarter revenue of $1.14 billion, beating analyst estimates of $1.09 billion, according to Benzinga Pro. The AI data cloud company reported second-quarter adjusted earnings of 35 cents per share, beating analyst estimates of 27 cents per share.

Snowflake shares jumped 14.2% to $228.88 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• Erayak Power Solution Group Inc. (NASDAQ:RAYA) gained 52.5% to $0.0717 in pre-market trading after gaining 9% on Wednesday.
• Top KingWin Ltd (NASDAQ:WAI) shares gained 50.5% to $0.2108 in pre-market trading after gaining around 24% on Wednesday.
• Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) gained 43.9% to $2.13 in pre-market trading after the company reported results for Telomir-1.
• AquaBounty Technologies, Inc. (NASDAQ:AQB) rose 27.7% to $1.16 in pre-market trading after gaining around 18% on Wednesday.
• Bollinger Innovations, Inc. (NASDAQ:BINI) gained 18% to $0.36 in pre-market trading.
• Garden Stage Limited (NASDAQ:GSIW) rose 18% to $0.1182 in pre-market trading.
• Phibro Animal Health Corporation (NASDAQ:PAHC) rose 16.5% to $37.55 in pre-market trading following strong fourth-quarter results that beat expectations.
• Pure Storage, Inc. (NYSE:PSTG) jumped 16.2% to $70.78 in pre-market trading after the company reported better-than-expected second-quarter financial results, issued third-quarter sales guidance above estimates, and raised its FY26 sales guidance above estimates.
• Oriental Rise Holdings Limited (NASDAQ:ORIS) gained 14.5% to $0.1260 in pre-market trading.

Losers

• CEL-SCI Corporation (NYSE:CVM) dipped 29.8% to $9.15 in pre-market trading following the cancer immunotherapy company's announcement of a $10 million public offering priced below current market levels.
• Telix Pharmaceuticals Limited (NASDAQ:TLX) fell 19.2% to $9.79 in pre-market trading after declining around 4% on Wednesday.
• The Cooper Companies, Inc. (NASDAQ:COO) declined 14.5% to $63.30 in pre-market trading after the company reported a third-quarter sales miss.
• Cognition Therapeutics, Inc. (NASDAQ:CGTX) fell 14.1% to $2.63 in pre-market trading after the company announced a $30 million registered direct offering of common stock.
• Domo, Inc. (NASDAQ:DOMO) declined 12.1% to $15.45 in pre-market trading following second-quarter results.
• Kalaris Therapeutics, Inc (NASDAQ:KLRS) fell 11.3% to $2.73 in the pre-market trading session after jumping 20% on Wednesday.  
• 707 Cayman Holdings Limited (NASDAQ:JEM) shares dipped 7.4% to $2.18 in pre-market trading after falling 9% on Wednesday.
• NetApp, Inc. (NASDAQ:NTAP) fell 7% to $104.30 in pre-market trading following first-quarter results.
• Nutanix, Inc. (NASDAQ:NTNX) dipped 5.3% to $65.92 in pre-market trading following the release of its fourth-quarter financial results.
• NVIDIA Corporation (NASDAQ:NVDA) fell 2% to $178.10 in pre-market trading. Nvidia reported better-than-expected earnings and sales results for the second quarter after the closing bell on Wednesday. The company also said it sees third-quarter revenue to be in a range of $52.92 billion to $55.08 billion, versus a Street consensus estimate of $52.96 billion, according to data from Benzinga Pro.

Now Read This:

• Wall Street’s Most Accurate Analysts Spotlight On 3 Tech & Telecom Stocks Delivering High-Dividend Yields

Photo via Shutterstock